Evidence-based valuation for long-term investors
DCF-based equity research, fair value rankings, and market expectation signals designed to help long-term investors evaluate global public companies with greater clarity.
Recent equity analyses
Individual company valuations based on financial statements, profitability, and discounted cash flow (DCF) analysis.

Natera Inc (NTRA) High Growth Meets Persistent Losses
Can growth outrun a business still losing money?

Zscaler Inc (ZS) Losses Challenge High Margin Strength
Can the balance sheet outlast losses at this scale?

Medline Inc (MDLN) Margins Tested by Expanding Scale
Can Medline keep margins intact while scaling a huge revenue base?

Live Nation Entertainment Inc (LYV) High Valuation Meets Thin Margins
Is today’s price assuming better returns on capital than shown?

Raymond James Financial Inc (RJF) Cash Strength Versus Market Pricing
How much is excess cash worth in a brokerage-led business?

Humana Inc (HUM) Margins Under Pressure Amid Growth
Can Humana keep margins intact while scaling premium revenue?
Market Price vs Intrinsic Value
Quick access to the most undervalued and overvalued stocks, ranked by their discount or premium to DCF-based fair value.
Stocks trading below fair value
Stocks trading above fair value
VDIX market valuation index
VDIX measures whether the market is expensive or cheap relative to intrinsic value. For each company, ValueDetect estimates fair value using a discounted cash flow (DCF) model, then compares it with the current share price to derive a RiskRatio. These signals are capped, weighted by market capitalization, and aggregated into a single market-wide score.
What would you like?
Continuously expanding company coverage — prioritized by user demand.
Suggest a company to analyze
Help shape what we analyze next.